<?xml version="1.0"?>
<?xml-stylesheet type="text/xsl" href="billres.xsl"?>
<!DOCTYPE bill PUBLIC "-//US Congress//DTDs/bill.dtd//EN" "bill.dtd">
<bill bill-stage="Introduced-in-Senate" dms-id="A1" public-private="public">
	<form>
		<distribution-code display="yes">II</distribution-code>
		<congress>110th CONGRESS</congress>
		<session>2d Session</session>
		<legis-num>S. 3151</legis-num>
		<current-chamber>IN THE SENATE OF THE UNITED STATES</current-chamber>
		<action>
			<action-date date="20080618">June 18, 2008</action-date>
			<action-desc><sponsor name-id="S307">Mr. Brown</sponsor> (for himself
			 and <cosponsor name-id="S249">Mr. Brownback</cosponsor>) introduced the
			 following bill; which was read twice and referred to the
			 <committee-name committee-id="SSHR00">Committee on Health, Education, Labor,
			 and Pensions</committee-name></action-desc>
		</action>
		<legis-type>A BILL</legis-type>
		<official-title>To amend the Federal Food, Drug, and Cosmetic Act with
		  respect to priority review vouchers.</official-title>
	</form>
	<legis-body>
		<section id="id44901ACF311A4F66B83B790FECB52006" section-type="section-one"><enum>1.</enum><header>Amendments regarding priority
			 review vouchers</header><text display-inline="no-display-inline">Section 524(b)
			 of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 360n(b)) is
			 amended—</text>
			<paragraph id="id5063F960F409484DB393B9EC1AA4B846"><enum>(1)</enum><text>by amending
			 paragraph (2) to read as follows:</text>
				<quoted-block display-inline="no-display-inline" id="id2C36830CCBDA40F89787D81BC0C317BF" style="OLC">
					<paragraph id="id36B89BBD0C554694A68A359BA8DBEF3D"><enum>(2)</enum><header>Transferability</header><text>Priority
				review vouchers shall be transferrable (including by sale). Entities eligible
				to participate in such transfers include sponsors of a human drug application
				under section 505(b)(1) or section 351 of the Public Health Service
				Act.</text>
					</paragraph><after-quoted-block>;
				and</after-quoted-block></quoted-block>
			</paragraph><paragraph id="idACFAE2C0C8C240B98DE07725FE6B6F1B"><enum>(2)</enum><text>in paragraph (3),
			 by adding at the end the following:</text>
				<quoted-block display-inline="no-display-inline" id="idF99DC8E7280F4927BA6EA32870CD2BFB" style="OLC">
					<subparagraph id="idD2EFB261A5BE4264AB7FDBB31AD4035F"><enum>(C)</enum><header>No effect on
				pending review</header><text>A priority review voucher may not be redeemed to
				affect the review of a pending human drug application under section 505(b)(1)
				or section 351 of the Public Health Service
				Act.</text>
					</subparagraph><after-quoted-block>.</after-quoted-block></quoted-block>
			</paragraph></section></legis-body>
</bill>
